There is more to this news than meets the eye.

Eli Lilly will cut prices for its weight loss drug Zepbound, with single-dose vials now available for $299 per month through ...

The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

The Food and Drug Administration is set to treat application under its priority program that seeks to accelerate the review ...

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...

By Stine Jacobsen, Maggie Fick and Jacob Gronholt-Pedersen COPENHAGEN (Reuters) -Novo Nordisk's closely watched Alzheimer's ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight loss.

By Mariam Sunny and Mrinalika Roy (Reuters) -Novo Nordisk reported promising mid-stage results for its experimental obesity ...